Ophthalmic Sciences For Profit

Op-Sci is developing a first in market AI technology to help 150M patients worldwide from going blind in a $7B market. The IOPerfect visor bridges the competition’s unmet need for user-friendly, accurate and affordable eye pressure tracking, a key biomarker for glaucoma management. Our team has over seventy years of combined experience backed by the world’s top glaucoma surgeons. We were already awarded $1.4M USD to reach proof of concept and are now seeking additional financing to get us to market readiness in 2023.

Founded Date: 2019-09-01
Headquarters: Tel Aviv, Tel Aviv, Israel
Technology: Biomarkers of Aging
Industry: AI for Longevity